Mahboubeh Rostami

2.0k total citations
99 papers, 1.5k citations indexed

About

Mahboubeh Rostami is a scholar working on Biomaterials, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Mahboubeh Rostami has authored 99 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Biomaterials, 31 papers in Organic Chemistry and 30 papers in Molecular Biology. Recurrent topics in Mahboubeh Rostami's work include Nanoparticle-Based Drug Delivery (35 papers), Synthesis and biological activity (11 papers) and RNA Interference and Gene Delivery (10 papers). Mahboubeh Rostami is often cited by papers focused on Nanoparticle-Based Drug Delivery (35 papers), Synthesis and biological activity (11 papers) and RNA Interference and Gene Delivery (10 papers). Mahboubeh Rostami collaborates with scholars based in Iran, United States and Canada. Mahboubeh Rostami's co-authors include Jaleh Varshosaz, Mina Mirian, Farshid Hassanzadeh, Ronald G. Crystal, Jason G. Mezey, Philip L. Leopold, Somayeh Taymouri, Sarah L. O’Beirne, Farshid Hassanzadeh and Yael Strulovici‐Barel and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Mahboubeh Rostami

94 papers receiving 1.5k citations

Peers

Mahboubeh Rostami
Mahboubeh Rostami
Citations per year, relative to Mahboubeh Rostami Mahboubeh Rostami (= 1×) peers Diego A. Chiappetta

Countries citing papers authored by Mahboubeh Rostami

Since Specialization
Citations

This map shows the geographic impact of Mahboubeh Rostami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mahboubeh Rostami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mahboubeh Rostami more than expected).

Fields of papers citing papers by Mahboubeh Rostami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mahboubeh Rostami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mahboubeh Rostami. The network helps show where Mahboubeh Rostami may publish in the future.

Co-authorship network of co-authors of Mahboubeh Rostami

This figure shows the co-authorship network connecting the top 25 collaborators of Mahboubeh Rostami. A scholar is included among the top collaborators of Mahboubeh Rostami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mahboubeh Rostami. Mahboubeh Rostami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rostami, Mahboubeh, et al.. (2025). Decoding fracture healing: A scoping review of mechanistic pathways derived from transcriptional analysis in murine studies. Bone. 194. 117444–117444. 1 indexed citations
2.
Rashidi, Anahita, Somayeh Taymouri, Mahboubeh Rostami, & Mina Mirian. (2024). Development of folic acid functionalized bilosomes for delivery of vorinostat to breast cancer cells: Characterization and cytocidal effects on MCF-7 and 4T1 breast cancer cell lines. Advanced Pharmaceutical Bulletin. 15(1). 82–94.
3.
4.
Mehri, Ali, et al.. (2023). Polyoxometalates as next-generation of theragnostic gadgets in cancer. Reviews in Inorganic Chemistry. 44(2). 271–287. 5 indexed citations
5.
Mehri, Ali, et al.. (2023). Pyrimido[4,5-b]indole Derivatives Bearing 1,2,4-oxadiazole Moiety As MDM2 Inhibitor Candidates in Cancer Treatment. Future Medicinal Chemistry. 15(6). 517–532. 2 indexed citations
6.
Azimian, Vajiheh, et al.. (2023). Anderson-type manganese polyoxomolybdate hybrid nanocomposite for boosting drug delivery against breast cancer. Journal of Drug Delivery Science and Technology. 87. 104778–104778. 3 indexed citations
7.
Rosenberg, Jonathan B., Bishnu P. De, Alvin Chen, et al.. (2023). Safety of Intravenous Administration of an AAV8 Vector Coding for an Oxidation-Resistant Human α1-Antitrypsin for the Treatment of α1-Antitrypsin Deficiency. Human Gene Therapy. 34(3-4). 139–149. 4 indexed citations
8.
Varshosaz, Jaleh, et al.. (2023). Arsenic Polyoxotungstate-Zeolitic Imidazolate Framework-8 as a Potential Selective Anti-cancer Nano Platform. Journal of Inorganic and Organometallic Polymers and Materials. 33(2). 611–624. 3 indexed citations
9.
Rostami, Mahboubeh, et al.. (2022). Oral epithelium response of electronic cigarette users to electronic cigarette. Journal of Oral Pathology and Medicine. 52(5). 431–439. 3 indexed citations
11.
Shahbazi‐Gahrouei, Daryoush, et al.. (2022). Novel MR imaging nanoprobe for hepatocellular carcinoma detection based on manganese–zinc ferrite nanoparticles: in vitro and in vivo assessments. Journal of Cancer Research and Clinical Oncology. 149(8). 4939–4957. 5 indexed citations
12.
Aliomrani, Mehdi, et al.. (2022). Copper‐Curcumin‐Bipyridine Dicarboxylate Complexes as Anticancer Candidates. Chemistry & Biodiversity. 19(10). e202200202–e202200202. 9 indexed citations
13.
Varshosaz, Jaleh, et al.. (2022). Redox responsive polymeric micelles of gellan gum/abietic acid for targeted delivery of ribociclib. International Journal of Biological Macromolecules. 215. 334–345. 19 indexed citations
14.
Rafiemanzelat, Fatemeh, Jaleh Varshosaz, Mina Mirian, et al.. (2022). Peptide-based pegylated polyurethane nanoparticles for paclitaxel delivery in HeLa cancer cells: the art of the architecture design in nanocarriers. Polymer Bulletin. 80(9). 10493–10531. 2 indexed citations
15.
Mirian, Mina, et al.. (2021). Boron phenyl alanine targeted ionic liquid decorated chitosan nanoparticles for mitoxantrone delivery to glioma cell line. Pharmaceutical Development and Technology. 26(8). 899–909. 13 indexed citations
16.
Javanmard, Shaghayegh Haghjooy, et al.. (2021). Novel Tocopherol Succinate-Polyoxomolybdate Bioconjugate as Potential Anti-Cancer Agent. Journal of Inorganic and Organometallic Polymers and Materials. 31(7). 3183–3195. 10 indexed citations
17.
Soltanabadi, Azim, Hojjat Sadeghi‐Aliabadi, Jaleh Varshosaz, et al.. (2021). Eudesmic acid-polyoxomolybdate organo-conjugate as novel anticancer agent. Journal of Molecular Structure. 1240. 130612–130612. 9 indexed citations
18.
Asadi, Parvin, et al.. (2021). Design, synthesis, biological evaluation, and molecular docking study on triazine based derivatives as anti-inflammatory agents. Journal of Molecular Structure. 1243. 130760–130760. 23 indexed citations
19.
Taymouri, Somayeh, et al.. (2019). Biotin decorated sunitinib loaded nanostructured lipid carriers for tumor targeted chemotherapy of lung cancer. Journal of Drug Delivery Science and Technology. 50. 237–247. 19 indexed citations
20.
Monshi, Ahmad, et al.. (2015). Synthesis and Characterization of Chitosan Coated Manganese Zinc Ferrite Nanoparticles as MRI Contrast Agents. SHILAP Revista de lepidopterología. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026